[go: up one dir, main page]

CN1812775B - 戊-1,5-二醇在制备用于抑制细菌生长的局部给药的药物中的用途 - Google Patents

戊-1,5-二醇在制备用于抑制细菌生长的局部给药的药物中的用途 Download PDF

Info

Publication number
CN1812775B
CN1812775B CN2004800177928A CN200480017792A CN1812775B CN 1812775 B CN1812775 B CN 1812775B CN 2004800177928 A CN2004800177928 A CN 2004800177928A CN 200480017792 A CN200480017792 A CN 200480017792A CN 1812775 B CN1812775 B CN 1812775B
Authority
CN
China
Prior art keywords
resistant
diol
fumycin
enterococci
glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2004800177928A
Other languages
English (en)
Chinese (zh)
Other versions
CN1812775A (zh
Inventor
J·法尔格曼
T·海德纳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ambria Dermatology AB
Original Assignee
Ambria Dermatology AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambria Dermatology AB filed Critical Ambria Dermatology AB
Publication of CN1812775A publication Critical patent/CN1812775A/zh
Application granted granted Critical
Publication of CN1812775B publication Critical patent/CN1812775B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02Acyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088Liquid substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/20Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
    • Y10T442/2525Coating or impregnation functions biologically [e.g., insect repellent, antiseptic, insecticide, bactericide, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN2004800177928A 2003-06-26 2004-06-23 戊-1,5-二醇在制备用于抑制细菌生长的局部给药的药物中的用途 Expired - Fee Related CN1812775B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE0301862A SE0301862D0 (sv) 2003-06-26 2003-06-26 Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier
SE03018629 2003-06-26
SE0301862-9 2003-06-26
PCT/SE2004/001001 WO2004112765A1 (fr) 2003-06-26 2004-06-23 Methode d'inhibition de la croissance de bacteries resistantes aux antibiotiques au moyen de pentane-1,5-diol

Publications (2)

Publication Number Publication Date
CN1812775A CN1812775A (zh) 2006-08-02
CN1812775B true CN1812775B (zh) 2011-07-27

Family

ID=27656597

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2004800177928A Expired - Fee Related CN1812775B (zh) 2003-06-26 2004-06-23 戊-1,5-二醇在制备用于抑制细菌生长的局部给药的药物中的用途

Country Status (16)

Country Link
US (1) US7973080B2 (fr)
EP (1) EP1635802B1 (fr)
JP (1) JP4824553B2 (fr)
KR (1) KR20060103817A (fr)
CN (1) CN1812775B (fr)
AT (1) ATE403421T1 (fr)
AU (1) AU2004249102A1 (fr)
BR (1) BRPI0411749A (fr)
CA (1) CA2529287A1 (fr)
DE (1) DE602004015597D1 (fr)
DK (1) DK1635802T3 (fr)
ES (1) ES2313038T3 (fr)
PL (1) PL1635802T3 (fr)
RU (1) RU2355392C9 (fr)
SE (1) SE0301862D0 (fr)
WO (1) WO2004112765A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1827433B2 (fr) 2004-11-29 2015-08-26 Ambria Dermatology AB Composition comprenant au moins 3 diols differents
JP2009517152A (ja) * 2005-11-29 2009-04-30 アンブリア ダーマトロジー アーベー 消臭剤としてのペンタン−1,5−ジオールを含む組成の使用
SE533425C2 (sv) 2008-07-07 2010-09-21 Ambria Dermatology Ab Antimikrobiell sammansättning
FR2940281B1 (fr) 2008-12-22 2011-04-01 Fabre Pierre Dermo Cosmetique Ester de diol et d'acide gras polyinsature comme agent anti-acne
CN103816165B (zh) * 2014-03-11 2019-03-01 北京德默高科医药技术有限公司 一种治疗痤疮的组合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136089A (en) * 1975-02-22 1979-01-23 Bayer Aktiengesellschaft Molded articles of crystalline poly (ethylene/alkylene) terephthalates which crystallize rapidly
DE3727128A1 (de) * 1987-08-14 1989-02-23 Bayer Ag Verfahren zur herstellung von in der waerme haertbaren einkomponenten-polyurethan-polyharnstoff-systemen
SG50568A1 (en) * 1989-01-31 1998-07-20 Novartis Ag High salt content rapid disinfection solution for contact lenses
US5369129A (en) * 1989-06-13 1994-11-29 Hydro Pharma Ab Preparation of topical treatment of infections caused by virus, bacteria and fungi
SE464060B (sv) 1989-06-13 1991-03-04 Gunnar Swanbeck Anvaendning av pentandiol eller hexandiol foer framstaellning av ett medel foer behandling av infektioner orsakade av herpesvirus
SE500777C2 (sv) 1992-04-14 1994-08-29 Hydro Pharma Ab Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav
US5370876A (en) * 1993-01-08 1994-12-06 Microbarriers Antimicrobial protective skin composition and method for protecting skin from body fluids
US5879690A (en) 1995-09-07 1999-03-09 Perricone; Nicholas V. Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
TR199802659T2 (xx) * 1996-06-20 1999-03-22 Lavipharm S.A. Topikal akne tedavisi i�in bir ara� ve tedavi y�ntemi.
GB9626513D0 (en) * 1996-12-20 1997-02-05 Bioglan Ireland R & D Ltd A pharmaceutical composition
IL155065A (en) * 1997-04-04 2004-01-04 Mitsubishi Pharma Corp History - 2 Aminopropene - 1, 3 - Diol and Pharmaceutical Preparations Containing Them
DE19741554B4 (de) * 1997-09-20 2005-04-14 Basf Coatings Ag Härtbare Beschichtungszusammensetzung sowie Verfahren zur Herstellung eines schützenden Überzugs
US6548074B1 (en) * 1999-07-22 2003-04-15 Elizabeth Arden Co., Division Of Conopco, Inc. Silicone elastomer emulsions stabilized with pentylene glycol
RU2160578C1 (ru) * 2000-04-10 2000-12-20 Открытое акционерное общество "Новосибхимфарм" Бактерицидный пластырь
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
RU2205033C2 (ru) * 2001-04-13 2003-05-27 Болдырев Сергей Николаевич Лечебный материал пролонгированного действия
US20020192273A1 (en) * 2001-06-15 2002-12-19 Teri Buseman Therapeutic patch useful for the treatment of hemorrhoids

Also Published As

Publication number Publication date
CN1812775A (zh) 2006-08-02
US7973080B2 (en) 2011-07-05
PL1635802T3 (pl) 2009-01-30
KR20060103817A (ko) 2006-10-04
EP1635802B1 (fr) 2008-08-06
CA2529287A1 (fr) 2004-12-29
ES2313038T3 (es) 2009-03-01
WO2004112765A1 (fr) 2004-12-29
JP4824553B2 (ja) 2011-11-30
EP1635802A1 (fr) 2006-03-22
SE0301862D0 (sv) 2003-06-26
AU2004249102A1 (en) 2004-12-29
RU2355392C9 (ru) 2009-07-27
JP2007521265A (ja) 2007-08-02
RU2355392C2 (ru) 2009-05-20
ATE403421T1 (de) 2008-08-15
DK1635802T3 (da) 2008-12-08
DE602004015597D1 (de) 2008-09-18
US20070020322A1 (en) 2007-01-25
BRPI0411749A (pt) 2006-08-08
RU2005140049A (ru) 2006-07-27

Similar Documents

Publication Publication Date Title
JP6956143B2 (ja) 抗微生物性組成物とその使用方法
Hübner et al. Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds
JP5693470B2 (ja) 銀イオンおよびメントールを含む消毒剤組成物並びにその使用
RU2653488C2 (ru) Композиция для местного лечения ран
US20100029780A1 (en) Topical composition
ES2534843T3 (es) Formulaciones antimicrobianas y anti-acné
JPH11279079A (ja) 高グリセリン含有抗微生物洗浄液
JP2019104757A (ja) 細菌性バイオフィルムを除去するためのセアプローゼの使用
WO2005044287A1 (fr) Composition desinfectante et ses procedes de fabrication et d'exploitation
US20250127802A1 (en) Halide-free ammonium silanes
CN1812775B (zh) 戊-1,5-二醇在制备用于抑制细菌生长的局部给药的药物中的用途
JP3577113B2 (ja) 皮膚外用剤
AU2003203452A8 (en) Topical composition
MXPA05013144A (es) Metodo para inhibir el crecimiento de bacterias resistentes a antibioticos con el uso de pentano-1,5-diol
MXPA06005233A (es) Composicion desinfectante y metodos para hacerla y usarla

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP02 Change in the address of a patent holder

Address after: Sweden Haab

Patentee after: AMBRIA DERMATOLOGY AB

Address before: Helsingborg

Patentee before: Ambria Dermatology AB

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110727

CF01 Termination of patent right due to non-payment of annual fee